Literature DB >> 12644941

Prognostic value of Hutchinson's sign in acute herpes zoster ophthalmicus.

Michel J W Zaal1, Hennie J Völker-Dieben, Joe D'Amaro.   

Abstract

PURPOSE: To determine the prognostic value of nasociliary skin lesions (Hutchinson's sign) for ocular inflammation and corneal sensory denervation in acute herpes zoster ophthalmicus.
METHODS: A longitudinal observational study with a 2-month follow-up was performed involving 83 non-immunocompromised adults with acute herpes zoster ophthalmicus, with a skin rash duration of less than 7 days, referred by their general practitioner. All skin lesions at the tip, the side and the root of the nose, representing the dermatomes of the external nasal and infratrochlear branches of the nasociliary nerve, were documented by taking photographs and marking anatomical drawings. Ocular inflammatory signs were observed by slit-lamp biomicroscopy, and corneal sensitivity was measured with the Cochet-Bonnet esthesiometer at 2-month follow-up.
RESULTS: Hutchinson's sign was a powerful predictor of ocular inflammation and corneal denervation in herpes zoster ophthalmicus [relative risks: 3.35 (CI 95%: 1.82-6.15) and 4.02 (CI 95%:1.55-10.42), respectively]. The manifestation of herpes zoster skin lesions at the dermatomes of both nasociliary branches was invariably associated with the development of ocular inflammation.
CONCLUSION: Clinicians should be alert for early skin lesions within the complete nasociliary dermatome, because they are a reliable prognostic sign of sight-threatening ocular complications in acute herpes zoster ophthalmicus.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12644941     DOI: 10.1007/s00417-002-0609-1

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.535


  15 in total

1.  THE NATURE OF HERPES ZOSTER: A LONG-TERM STUDY AND A NEW HYPOTHESIS.

Authors:  R E HOPE-SIMPSON
Journal:  Proc R Soc Med       Date:  1965-01

2.  Herpes zoster ophthalmicus--the changing epidemiology and its implications for treatment.

Authors:  S R Seiff; A M Mehta
Journal:  West J Med       Date:  1990-10

3.  Corneal exposure in herpes zoster ophthalmicus.

Authors:  T Potamitis; J N O'Sullivan; I Mohan-Roberts
Journal:  Br J Gen Pract       Date:  1997-05       Impact factor: 5.386

Review 4.  Ophthalmic herpes zoster.

Authors:  R J Marsh; M Cooper
Journal:  Eye (Lond)       Date:  1993       Impact factor: 3.775

5.  Herpes zoster ophthalmicus in Malawi.

Authors:  S Lewallen
Journal:  Ophthalmology       Date:  1994-11       Impact factor: 12.079

6.  Complications of herpes zoster ophthalmicus.

Authors:  L W Womack; T J Liesegang
Journal:  Arch Ophthalmol       Date:  1983-01

7.  Herpes zoster ophthalmicus in patients with human immunodeficiency virus infection.

Authors:  T P Margolis; M S Milner; A Shama; W Hodge; S Seiff
Journal:  Am J Ophthalmol       Date:  1998-03       Impact factor: 5.258

8.  Latent varicella-zoster viral DNA in human trigeminal and thoracic ganglia.

Authors:  R Mahalingam; M Wellish; W Wolf; A N Dueland; R Cohrs; A Vafai; D Gilden
Journal:  N Engl J Med       Date:  1990-09-06       Impact factor: 91.245

9.  Racial differences in the occurrence of herpes zoster.

Authors:  K Schmader; L K George; B M Burchett; C F Pieper; J D Hamilton
Journal:  J Infect Dis       Date:  1995-03       Impact factor: 5.226

10.  Natural history of herpes zoster ophthalmicus: predictors of postherpetic neuralgia and ocular involvement.

Authors:  S P Harding; J R Lipton; J C Wells
Journal:  Br J Ophthalmol       Date:  1987-05       Impact factor: 4.638

View more
  12 in total

Review 1.  Herpes zoster epidemiology, management, and disease and economic burden in Europe: a multidisciplinary perspective.

Authors:  Robert W Johnson; Marie-José Alvarez-Pasquin; Marc Bijl; Elisabetta Franco; Jacques Gaillat; João G Clara; Marc Labetoulle; Jean-Pierre Michel; Luigi Naldi; Luis S Sanmarti; Thomas Weinke
Journal:  Ther Adv Vaccines       Date:  2015-07

Review 2.  Managing ophthalmic herpes zoster in primary care.

Authors:  Wim Opstelten; Michel J W Zaal
Journal:  BMJ       Date:  2005-07-16

3.  Herpes zoster ophthalmicus in a healthy child.

Authors:  Carlos G Teran; Marsha Medows
Journal:  BMJ Case Rep       Date:  2013-05-21

4.  Herpes zoster ophthalmicus reduction: implementation of shingles vaccination in the UK.

Authors:  A Potts; G J Williams; J A Olson; K G J Pollock; H Murdoch; J C Cameron
Journal:  Eye (Lond)       Date:  2014-03       Impact factor: 3.775

5.  Herpes zoster ophthalmicus: is the globe involved?

Authors:  Judit Szent-Ivanyi; Ali S Hassan; Masoud Teimory
Journal:  BMJ Case Rep       Date:  2014-04-17

6.  Herpes zoster ophthalmicus.

Authors:  Thomas Catron; H Gene Hern
Journal:  West J Emerg Med       Date:  2008-08

7.  Herpes zoster ophthalmicus.

Authors:  Srinivasan Sanjay; Philemon Huang; Raghavan Lavanya
Journal:  Curr Treat Options Neurol       Date:  2011-02       Impact factor: 3.972

Review 8.  The Neuralgias.

Authors:  Danielle Wilhour; Stephanie J Nahas
Journal:  Curr Neurol Neurosci Rep       Date:  2018-08-16       Impact factor: 6.030

9.  Diffusion tensor magnetic resonance imaging of trigeminal nerves in relapsing herpetic keratouveitis.

Authors:  Antoine Rousseau; Ghaïdaa Nasser; Christophe Chiquet; Emmanuel Barreau; Gael Gendron; Godefroy Kaswin; Mohamed M'Garrech; Farida Benoudiba; Denis Ducreux; Marc Labetoulle
Journal:  PLoS One       Date:  2015-04-01       Impact factor: 3.240

Review 10.  Evaluation of efficacy and effectiveness of live attenuated zoster vaccine.

Authors:  G Gabutti; N Valente; N Sulcaj; A Stefanati
Journal:  J Prev Med Hyg       Date:  2014-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.